DNTH Dianthus Therapeutics, Inc. - Common Stock
O Dianthus Therapeutics, Inc. - Common Stock Przegląd firmy z Wikipedii
DNTH Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
DNTH Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
DNTH Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
- Mocne kupno 10 45,5%
- Kup 11 50,0%
- Trzymaj 1 4,5%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
13 analityków · 2026-08-15Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $-0.90 | $-0.87 | -0.03% |
| 31 marca 2026 | $-0.85 | $-1.09 | 0.24% |
| 31 grudnia 2025 | $-1.43 | $-1.10 | -0.33% |
| 30 września 2025 | $-0.97 | $-0.88 | -0.09% |
| 30 czerwca 2025 | $-0.88 | $-0.89 | 0.01% |
| 31 marca 2025 | $-0.82 | $-0.87 | 0.05% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| DNTH | $1.78B | -9.8 | -67.3% | -7973.3% | -40.8% | — |
| CGON | $3.35B | -20.0 | 254.7% | -3985.0% | -22.6% | — |
| COGT | $5.72B | -16.4 | — | — | -83.1% | — |
| MIRM | $4.10B | -168.1 | 54.7% | -4.5% | -8.2% | — |
| ERAS | $1.06B | -8.5 | — | — | -35.7% | — |
| SRRK | $4.78B | -13.4 | — | — | -157.9% | — |
| CAI | $7.62B | -8.4 | 97.0% | -8.4% | -13.2% | — |
| PTCT | $6.19B | 9.8 | 114.5% | 39.4% | -331.5% | — |
| TVTX | $3.47B | -131.8 | 110.5% | -5.2% | -34.6% | — |
| ACAD | $4.55B | 11.6 | 11.9% | 36.5% | 38.1% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $6M | $3M | · | · | · | $0 | $0 | $0 | |
| R&D Expense | $146M | $83M | $33M | $29M | $47M | $51M | $59M | $41M | $28M | |
| SG&A Expense | $34M | $25M | $18M | $7M | $28M | $28M | $24M | $19M | $8M | |
| Operating Expenses | $180M | $108M | $51M | $36M | $75M | $79M | $83M | $60M | $36M | |
| Operating Income | $-178M | $-102M | $-48M | $-30M | $-75M | $-79M | $-83M | $-60M | $-36M | |
| Interest Income | $16M | $17M | $5M | · | · | · | · | · | · | |
| Other Non-op | $-974.0K | $-554.0K | $-60.0K | $-52.0K | · | · | · | $2M | $236.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-162M | $-85M | $-44M | $-28M | $-71M | $-75M | $-77M | $-58M | $-35M | |
| EPS (Basic) | $-4.20 | $-2.55 | $-8.45 | $-32.57 | $-1.29 | $-1.71 | · | · | · | |
| EPS (Diluted) | $-4.20 | $-2.55 | $-8.45 | $-32.57 | $-1.29 | $-1.71 | · | · | · | |
| Shares (Basic) | 38,617,580 | 33,313,849 | 5,153,423 | 874,234 | 54,948,808 | 43,920,121 | · | · | · | |
| Shares (Diluted) | 38,617,580 | 33,313,849 | 5,153,423 | 874,234 | 54,948,808 | 43,920,121 | · | · | · | |
| EBITDA | $-178M | $-102M | $-48M | · | $-73M | $-77M | $-81M | $-59M | · |
Bilans 22
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $51M | $23M | $132M | $15M | $132M | $58M | $65M | $58M | $51M | |
| Short-term Investments | $353M | $252M | $41M | $60M | $45M | $91M | $81M | $84M | · | |
| Receivables | $52.0K | $0 | $294.0K | $5M | · | · | · | · | · | |
| Prepaid Expense | $5M | $5M | $3M | $905.0K | $4M | $3M | $4M | $3M | $936.0K | |
| Other Current Assets | $86.0K | $355.0K | $0 | · | · | · | · | · | · | |
| Current Assets | $409M | $281M | $177M | $82M | $181M | $152M | $150M | $145M | $53M | |
| PP&E (Net) | $296.0K | $194.0K | $185.0K | $142.0K | $7M | $8M | $10M | $10M | $2M | |
| PP&E (Gross) | $600.0K | $387.0K | $282.0K | $172.0K | $14M | $13M | $13M | $11M | $2M | |
| Accum. Depreciation | $304.0K | $193.0K | $97.0K | $30.0K | $7M | $5M | $3M | $1M | $382.0K | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | $4.0K | |
| Total Assets | $531M | $374M | $179M | $83M | $190M | $162M | $162M | $157M | $54M | |
| Accounts Payable | $10M | $5M | $3M | $1M | $3M | $4M | $3M | $3M | $167.0K | |
| Accrued Liabilities | $19M | $13M | $7M | $7M | $8M | $8M | $11M | $7M | $4M | |
| Current Liabilities | $31M | $18M | $10M | $8M | $11M | $11M | $14M | $10M | $4M | |
| Capital Leases | $1M | $1M | $168.0K | $438.0K | $0 | · | · | · | · | |
| Total Liabilities | $38M | $22M | $11M | $9M | $17M | $18M | $20M | $12M | $4M | |
| Common Stock | $43.0K | $31.0K | $15.0K | $0 | $59.0K | $49.0K | $39.0K | $33.0K | $2.0K | |
| Retained Earnings | $-337M | $-174M | $-89M | $-46M | $-326M | $-254M | $-179M | $-103M | $-45M | |
| AOCI | $489.0K | $106.0K | $47.0K | $-161.0K | $-30.0K | $-23.0K | $8.0K | $-8.0K | · | |
| Stockholders' Equity | $493M | $352M | $169M | $-44M | $-17M | $144M | $141M | $146M | $-42M | |
| Liabilities + Equity | $531M | $374M | $179M | $83M | $190M | $162M | $162M | $157M | $54M | |
| Shares Outstanding | 43,223,090 | 31,115,341 | 14,817,696 | 875,279 | 58,799,157 | 48,533,135 | 39,260,532 | 33,305,033 | 2,351,247 |
Przepływy pieniężne 12
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | $2M | $2M | $2M | $2M | $875.0K | $376.0K | |
| Stock-based Comp | $23M | $13M | $3M | $2M | $10M | $10M | $10M | $11M | $2M | |
| Other Non-cash | · | · | · | · | $-723.0K | $-1M | $8M | $4M | · | |
| Operating Cash Flow | $-129M | $-78M | $-37M | $-29M | $-60M | $-64M | $-57M | $-42M | $-22M | |
| CapEx | · | · | · | $314.0K | $1M | $400.0K | $3M | $8M | $2M | |
| Investing Cash Flow | $-123M | $-287M | $20M | $-60M | $43M | $-11M | $2M | $-92M | $-2M | |
| Stock Issued | $317.0K | $0 | $0 | $3M | $0 | $65M | $61M | $93M | · | |
| Net Stock Activity | $317.0K | $39M | · | · | · | $65M | $61M | · | · | |
| Financing Cash Flow | $280M | $256M | $134M | $97M | $90M | $68M | $62M | $142M | $71M | |
| Net Change in Cash | $28M | $-109M | $117M | $8M | $73M | $-7M | $7M | $9M | $47M | |
| Taxes Paid | $0 | $0 | $0 | $0 | · | · | · | · | · | |
| Free Cash Flow | · | · | · | · | $-61M | $-64M | $-60M | $-50M | · |
Rentowność 5
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -8739.3% | -1633.7% | · | · | · | · | · | · | · | |
| Net Margin | -7973.3% | -1362.8% | · | · | · | · | · | · | · | |
| EBITDA Margin | -8739.3% | -1633.7% | · | · | · | · | · | · | · | |
| ROA | -35.9% | -30.7% | -33.2% | · | -40.5% | -46.4% | -48.2% | -54.3% | · | |
| ROE | -40.8% | -24.6% | -25.1% | · | -39.3% | -49.5% | -50.7% | -37.7% | · |
Płynność i wypłacalność 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 13.3 | 15.2 | 18.4 | · | 16.6 | 13.3 | 10.6 | 13.9 | · | |
| Quick Ratio | 13.2 | 15.0 | 18.1 | · | 16.3 | 13.0 | 10.3 | 13.7 | · |
Efektywność 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | · | · | · | 0.0 | 0.0 | · | |
| Receivables Turnover | 78.3 | 11.3 | · | · | · | · | · | · | · |
Stopy Wzrostu 1
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -67.3% | 120.6% | · | · | · | · | · | · | · |
Wycena (TTM) 10
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $6M | $3M | · | $0 | $0 | $0 | $0 | · | |
| Net Income TTM | $-162M | $-85M | $-44M | $-28M | $-71M | $-75M | $-77M | $-58M | · | |
| Market Cap | $1.78B | $678M | $154M | · | $4.17B | $6.09B | $9.52B | $3.04B | · | |
| P/E | -9.8 | -8.5 | -1.2 | -0.2 | -54.9 | -73.4 | · | · | · | |
| P/S | 874.9 | 108.8 | 54.5 | · | · | · | · | · | · | |
| P/B | 3.6 | 1.9 | 0.9 | · | 24.1 | 42.3 | 67.4 | 20.9 | · | |
| P / Tangible Book | 3.6 | 1.9 | 0.9 | · | · | 42.3 | · | · | · | |
| P / Cash Flow | -13.8 | -8.7 | -4.2 | · | -70.0 | -95.1 | -166.8 | -72.5 | · | |
| P / FCF | · | · | · | · | -68.6 | -94.5 | -158.3 | -61.3 | · | |
| Earnings Yield | -10.2% | -11.7% | -81.2% | -508.9% | -1.8% | -1.4% | · | · | · |
Rachunek zysków i strat 13
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $284.0K | $396.0K | $193.0K | $1M | $1M | $2M | $2M | $874.0K | $457.0K | $924.0K | · | · | · | $1M | |
| R&D Expense | $49M | $35M | $60M | $32M | $26M | $27M | $26M | $26M | $18M | $13M | $9M | $8M | $10M | $6M | $-6M | $7M | |
| SG&A Expense | $14M | $12M | $10M | $8M | $9M | $7M | $7M | $7M | $6M | $6M | $5M | $9M | $2M | $2M | $-9M | $2M | |
| Operating Expenses | $62M | $47M | $70M | $41M | $35M | $34M | $33M | $32M | $24M | $19M | $13M | $17M | $13M | $8M | $-15M | $9M | |
| Operating Income | $-61M | $-47M | $-70M | $-40M | $-35M | $-33M | $-32M | $-30M | $-22M | $-18M | $-13M | $-16M | $-12M | $-8M | $20M | $-8M | |
| Interest Income | $12M | $6M | $11M | $1M | $3M | $4M | $7M | $2M | $4M | $4M | · | · | · | · | · | · | |
| Other Non-op | $-370.0K | $-249.0K | $-409.0K | $-360.0K | $-107.0K | $-98.0K | $-382.0K | $22.0K | $-80.0K | $-114.0K | $-19.0K | $-15.0K | $-23.0K | $-3.0K | $-43.0K | $-2.0K | |
| Net Income | $-50M | $-41M | $-64M | $-37M | $-32M | $-30M | $-28M | $-25M | $-18M | $-14M | $-11M | $-15M | $-11M | $-7M | $-10M | $-8M | |
| EPS (Basic) | $-0.90 | $-0.85 | $-1.53 | $-0.97 | $-0.88 | $-0.82 | $-0.76 | $-0.74 | $-0.51 | $-0.54 | $16.16 | $-3.78 | $-12.73 | $-8.10 | $-22.99 | $-8.90 | |
| EPS (Diluted) | $-0.90 | $-0.85 | $-1.53 | $-0.97 | $-0.88 | $-0.82 | $-0.76 | $-0.74 | $-0.51 | $-0.54 | $16.16 | $-3.78 | $-12.73 | $-8.10 | $-22.99 | $-8.90 | |
| Shares (Basic) | 56,029,124 | 48,032,742 | -70,789,516 | 37,794,088 | 35,822,308 | 35,790,700 | -60,815,392 | 34,236,728 | 34,227,038 | 25,665,475 | -503,072 | 3,906,886 | 874,900 | 874,709 | -117,614,793 | 874,327 | |
| Shares (Diluted) | 56,029,124 | 48,032,742 | -70,789,516 | 37,794,088 | 35,822,308 | 35,790,700 | -60,815,392 | 34,236,728 | 34,227,038 | 25,665,475 | -503,072 | 3,906,886 | 874,900 | 874,709 | -117,614,793 | 874,327 | |
| EBITDA | $-61M | $-47M | · | $-40M | $-35M | $-33M | · | $-30M | $-22M | $-18M | · | $-16M | $-7M | $-32M | · | $-17M |
Bilans 21
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $111M | $628M | $51M | $56M | $13M | $10M | $23M | $34M | $314M | $330M | $132M | $157M | $63M | $49M | $15M | $59M | |
| Short-term Investments | $776M | $484M | $353M | $347M | $244M | $253M | $252M | $247M | $47M | $47M | $41M | $33M | · | · | $60M | $69M | |
| Receivables | $106.0K | $1M | $52.0K | $5M | $39.0K | $1M | $0 | $1M | $840.0K | $435.0K | $294.0K | $232.0K | · | · | $5M | · | |
| Prepaid Expense | $11M | $7M | $5M | $6M | $6M | $7M | $5M | $4M | $3M | $3M | $3M | $832.0K | $1M | $3M | $905.0K | $4M | |
| Other Current Assets | $184.0K | $83.0K | $86.0K | $73.0K | $111.0K | $392.0K | $355.0K | · | · | · | $0 | · | · | · | · | · | |
| Current Assets | $898M | $1.12B | $409M | $414M | $264M | $271M | $281M | $287M | $366M | $381M | $177M | $191M | $79M | $83M | $82M | $132M | |
| PP&E (Net) | $418.0K | $274.0K | $296.0K | $185.0K | $207.0K | $191.0K | $194.0K | $189.0K | $189.0K | $195.0K | $185.0K | $195.0K | $0 | $0 | $142.0K | $6M | |
| PP&E (Gross) | $791.0K | $610.0K | $600.0K | $462.0K | $457.0K | $411.0K | $387.0K | $356.0K | $331.0K | $314.0K | $282.0K | $272.0K | · | · | $172.0K | · | |
| Accum. Depreciation | $373.0K | $336.0K | $304.0K | $277.0K | $250.0K | $220.0K | $193.0K | $167.0K | $142.0K | $119.0K | $97.0K | $77.0K | · | · | $30.0K | · | |
| Total Assets | $1.21B | $1.25B | $531M | $577M | $326M | $349M | $374M | $354M | $369M | $382M | $179M | $192M | $79M | $83M | $83M | $164M | |
| Accounts Payable | $6M | $5M | $10M | $7M | $5M | $8M | $5M | $8M | $4M | $3M | $3M | $1M | $813.0K | $1M | $1M | $3M | |
| Accrued Liabilities | $26M | $31M | $19M | $16M | $14M | $8M | $13M | $8M | $6M | $6M | $7M | $11M | · | · | $7M | $7M | |
| Current Liabilities | $34M | $38M | $31M | $24M | $20M | $17M | $18M | $16M | $10M | $9M | $10M | $13M | $4M | $6M | $8M | $13M | |
| Capital Leases | $913.0K | $965.0K | $1M | $1M | $1M | $1M | $1M | $0 | $30.0K | $97.0K | $168.0K | $257.0K | $0 | $0 | $438.0K | $27M | |
| Total Liabilities | $41M | $46M | $38M | $31M | $23M | $20M | $22M | $16M | $11M | $10M | $11M | $14M | $4M | $6M | $9M | $40M | |
| Common Stock | $55.0K | $54.0K | $43.0K | $43.0K | $32.0K | $32.0K | $31.0K | $29.0K | $29.0K | $29.0K | $15.0K | $15.0K | $61.0K | $61.0K | $0 | $61.0K | |
| Retained Earnings | $-428M | $-378M | $-337M | $-272M | $-236M | $-204M | $-174M | $-146M | $-121M | $-103M | $-89M | $-79M | $-434M | $-431M | $-46M | $-382M | |
| AOCI | $-2M | $-575.0K | $489.0K | $163.0K | $98.0K | $270.0K | $106.0K | $681.0K | $-37.0K | $-27.0K | $47.0K | $-4.0K | $-3.0K | $-16.0K | $-161.0K | $-462.0K | |
| Stockholders' Equity | $1.17B | $1.20B | $493M | $546M | $303M | $329M | $352M | $338M | $358M | $373M | $169M | $178M | $75M | $77M | $-44M | $124M | |
| Liabilities + Equity | $1.21B | $1.25B | $531M | $577M | $326M | $349M | $374M | $354M | $369M | $382M | $179M | $192M | $79M | $83M | $83M | $164M | |
| Shares Outstanding | 54,798,338 | 54,582,749 | 43,223,090 | 42,854,563 | 32,176,482 | 32,125,933 | 31,115,341 | 29,366,352 | 29,352,140 | 29,348,626 | 14,817,696 | 14,817,762 | 60,652,197 | 60,648,821 | 875,279 | 60,555,520 |
Przepływy pieniężne 13
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $421.0K | · | $471.0K | |
| Stock-based Comp | $12M | $11M | $6M | $6M | $6M | $5M | $4M | $4M | $3M | $2M | $726.0K | $1M | $489.0K | $533.0K | $513.0K | $-3M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | · | · | $2M | $18M | · | · | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | · | · | · | $-7M | · | · | |
| Operating Cash Flow | $-49M | $-29M | $-47M | $-31M | $-24M | $-28M | $-27M | $-21M | $-15M | $-15M | $-12M | $17M | $21M | $-10M | $-9M | $16M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $245.0K | · | $158.0K | |
| Investing Cash Flow | $-479M | $-134M | $37M | $-201M | $26M | $15M | $-23M | $-259M | $1M | $-6M | $-8M | $-17M | $13M | $18M | $-13M | $-7M | |
| Stock Issued | $0 | $120.0K | $1.0K | $187.0K | $0 | $129.0K | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Stock Activity | · | $120.0K | · | · | · | $129.0K | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $10M | $739M | $5M | $275M | $568.0K | $161.0K | $40M | $296.0K | $-2M | $218M | $-5M | $138M | $0 | $0 | $0 | $97M | |
| Net Change in Cash | $-517M | $577M | $-5M | $43M | $3M | $-13M | $-11M | $-280M | $-16M | $197M | $-25M | $139M | $34M | $8M | $-22M | $106M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | $0 | $0 | · | · | $0 | $0 | · | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | $-36M | · | · |
Rentowność 5
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -10173.7% | -18096.9% | -2852.7% | · | · | · | · | · | -1705.5% | · | · | · | · | |
| Net Margin | · | · | · | -9284.1% | -16388.1% | -2537.5% | · | · | · | · | · | -1597.7% | · | · | · | · | |
| EBITDA Margin | · | · | · | -10173.7% | -18096.9% | -2852.7% | · | · | · | · | · | -1705.5% | · | · | · | · | |
| ROA | -6.5% | -5.1% | · | -7.9% | -9.1% | -8.1% | · | -9.2% | -7.9% | -5.9% | · | -8.3% | -2.6% | -21.0% | · | -8.7% | |
| ROE | -6.8% | -5.3% | · | -8.3% | -9.6% | -8.4% | · | -9.8% | -8.1% | -6.1% | · | -9.8% | -3.1% | -25.5% | · | -10.2% |
Płynność i wypłacalność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 26.1 | 29.3 | · | 17.3 | 13.1 | 16.0 | · | 18.3 | 36.5 | 42.5 | · | 14.6 | 19.5 | 13.9 | · | 10.2 | |
| Quick Ratio | 25.8 | 29.1 | · | 17.1 | 12.8 | 15.6 | · | 18.0 | 36.1 | 42.1 | · | 14.5 | 15.5 | 8.1 | · | 9.9 |
Efektywność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.0 | 0.0 | · | · | · | · | · | 0.0 | · | · | · | · | |
| Receivables Turnover | · | · | · | 0.1 | 0.4 | 1.6 | · | · | · | · | · | 8.0 | · | · | · | · |
Wycena (TTM) 10
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4M | $4M | · | $4M | $5M | $6M | · | $6M | · | · | · | · | · | · | · | · | |
| Net Income TTM | $-159M | $-139M | · | $-123M | $-104M | $-86M | · | $-71M | $-57M | $-47M | · | $-41M | $-32M | $-25M | · | $-36M | |
| Market Cap | $5.34B | $4.58B | · | $1.69B | $599M | $583M | · | $804M | $760M | $880M | · | $203M | $738M | $767M | · | $1.37B | |
| P/E | -27.1 | -23.8 | · | -11.5 | -6.3 | -7.0 | · | -4.9 | -1.5 | -1.2 | · | -0.4 | -0.4 | -0.7 | · | -2.3 | |
| P/S | 1361.3 | 1167.3 | · | 429.7 | 111.2 | 96.0 | · | 137.8 | · | · | · | · | · | · | · | · | |
| P/B | 4.6 | 3.8 | · | 3.1 | 2.0 | 1.8 | · | 2.4 | 2.1 | 2.4 | · | 1.1 | 9.9 | 9.9 | · | 11.0 | |
| P / Tangible Book | 4.6 | 3.8 | · | 3.1 | 2.0 | 1.8 | · | 2.4 | 2.1 | 2.4 | · | 1.1 | 9.9 | 9.9 | · | 11.0 | |
| P / Cash Flow | · | -158.7 | · | · | · | -21.1 | · | · | · | -58.9 | · | · | · | -21.5 | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | -21.4 | · | · | |
| Earnings Yield | -3.7% | -4.2% | · | -8.7% | -15.8% | -14.4% | · | -20.3% | -67.8% | -83.8% | · | -245.1% | -246.9% | -139.9% | · | -43.8% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $2M | $6M | $3M | — | — |
| Marża Operacyjna % | -8739.3% | -1633.7% | — | — | — |
| Zysk netto | $-162M | $-85M | $-44M | $-28M | $-71M |
| Rozwodniony EPS | $-4.20 | $-2.55 | $-8.45 | $-32.57 | $-1.29 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 13.3 | 15.2 | 18.4 | — | 16.6 |
| Wskaźnik Szybkości | 13.2 | 15.0 | 18.1 | — | 16.3 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | — | — | — | — | $-61M |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 283 emitenci · $4.7B łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 66 (-30 vs poprzedni kw.) | 29 (+12 vs poprzedni kw.) | 111 (+32 vs poprzedni kw.) | 69 (+12 vs poprzedni kw.) | +6.7M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| FMR LLC | $572 883 234 | 5 876 931 | 12,24% | Akcje |
| WELLINGTON MANAGEMENT GROUP LLP | $264 170 313 | 2 709 995 | 5,64% | Akcje |
| Fairmount Funds Management LLC | $247 325 379 | 2 537 191 | 5,28% | Akcje |
| STATE STREET CORP | $229 798 634 | 2 357 440 | 4,91% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $210 514 689 | 2 159 568 | 4,50% | Akcje |
| Avidity Partners Management LP | $205 115 856 | 2 104 184 | 4,38% | Akcje |
| Octagon Capital Advisors LP | $179 525 699 | 1 841 667 | 3,83% | Akcje |
| TCG Crossover Management, LLC | $163 437 308 | 1 676 624 | 3,49% | Akcje |
| FRED ALGER MANAGEMENT, LLC | $126 967 018 | 1 302 493 | 2,71% | Akcje |
| Venrock Adviser, LLC | $115 026 400 | 1 180 000 | 2,46% | Akcje |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $109 695 511 | 1 125 313 | 2,34% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $107 328 005 | 1 100 843 | 2,29% | Akcje |
| Polar Capital Holdings Plc | $99 305 410 | 1 018 726 | 2,12% | Akcje |
| CITADEL ADVISORS LLC | $95 034 324 | 974 911 | 2,03% | Akcje |
| JENNISON ASSOCIATES LLC | $83 073 817 | 852 214 | 1,77% | Akcje |
| BAKER BROS. ADVISORS LP | $83 068 947 | 852 164 | 1,77% | Akcje |
| Logos Global Management LP | $77 984 000 | 800 000 | 1,67% | Akcje |
| VANGUARD GROUP INC | $75 241 465 | 1 825 806 | 1,61% | Akcje |
| Cormorant Asset Management, LP | $73 110 000 | 750 000 | 1,56% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $70 001 868 | 834 150 | 1,50% | Akcje |
| BRAIDWELL LP | $57 957 904 | 594 562 | 1,24% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $55 574 810 | 570 115 | 1,19% | Akcje |
| AMERIPRISE FINANCIAL INC | $49 641 680 | 509 247 | 1,06% | Akcje |
| Woodline Partners LP | $48 793 419 | 500 548 | 1,04% | Akcje |
| MPM BIOIMPACT LLC | $40 941 795 | 420 002 | 0,87% | Akcje |
| Affinity Asset Advisors, LLC | $38 992 000 | 400 000 | 0,83% | Akcje |
| SILVERARC CAPITAL MANAGEMENT, LLC | $38 017 200 | 390 000 | 0,81% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $35 674 073 | 365 963 | 0,76% | Akcje |
| Bain Capital Life Sciences Investors, LLC | $35 333 576 | 362 470 | 0,75% | Akcje |
| Spruce Street Capital LP | $34 587 464 | 354 816 | 0,74% | Akcje |
| Vivo Capital, LLC | $34 507 725 | 353 998 | 0,74% | Akcje |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $30 697 817 | 314 914 | 0,66% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $29 702 156 | 304 700 | 0,63% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $29 485 945 | 302 482 | 0,63% | Akcje |
| Driehaus Capital Management LLC | $28 782 530 | 295 266 | 0,61% | Akcje |
| First Turn Management, LLC | $27 856 957 | 285 771 | 0,59% | Akcje |
| Assenagon Asset Management S.A. | $27 357 665 | 280 649 | 0,58% | Akcje |
| TANG CAPITAL MANAGEMENT LLC | $25 802 176 | 264 692 | 0,55% | Akcje |
| Artisan Partners Limited Partnership | $25 176 062 | 258 269 | 0,54% | Akcje |
| RTW INVESTMENTS, LP | $24 181 181 | 248 063 | 0,52% | Akcje |
| EMERALD ADVISERS, LLC | $24 156 031 | 247 805 | 0,52% | Akcje |
| Pictet Asset Management Holding SA | $24 106 317 | 247 295 | 0,51% | Akcje |
| TD Asset Management Inc | $21 965 558 | 225 334 | 0,47% | Akcje |
| EVENTIDE ASSET MANAGEMENT, LLC | $21 958 442 | 225 261 | 0,47% | Akcje |
| Candriam S.C.A. | $19 887 628 | 204 214 | 0,42% | Akcje |
| STEMPOINT CAPITAL LP | $19 578 955 | 200 851 | 0,42% | Akcje |
| Qube Research & Technologies Ltd | $19 196 152 | 196 924 | 0,41% | Akcje |
| BANK OF AMERICA CORP /DE/ | $19 072 742 | 195 658 | 0,41% | Akcje |
| Nicholas Investment Partners, LP | $18 206 242 | 186 769 | 0,39% | Akcje |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $18 033 800 | 185 000 | 0,39% | Akcje |
| GOLDMAN SACHS GROUP INC | $17 941 974 | 184 058 | 0,38% | Akcje |
| Ensign Peak Advisors, Inc | $16 979 749 | 174 187 | 0,36% | Akcje |
| Artia Global Partners LP | $15 888 265 | 162 990 | 0,34% | Akcje |
| Balyasny Asset Management L.P. | $15 792 247 | 162 005 | 0,34% | Akcje |
| Alyeska Investment Group, L.P. | $14 679 708 | 150 592 | 0,31% | Akcje |
| Eagle Health Investments LP | $12 803 413 | 131 344 | 0,27% | Akcje |
| EMERALD MUTUAL FUND ADVISERS TRUST | $12 771 635 | 131 018 | 0,27% | Akcje |
| PFM Health Sciences, LP | $11 816 721 | 121 222 | 0,25% | Akcje |
| Tri Locum Partners LP | $11 767 006 | 120 712 | 0,25% | Akcje |
| ORBIMED ADVISORS LLC | $11 210 200 | 115 000 | 0,24% | Akcje |
| Patient Square Capital LP | $10 527 840 | 108 000 | 0,22% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $10 474 713 | 107 455 | 0,22% | Akcje |
| NEUBERGER BERMAN GROUP LLC | $10 217 951 | 104 821 | 0,22% | Akcje |
| Caption Management, LLC | $10 128 172 | 103 900 | 0,22% | Opcja kupna |
| SEVEN GRAND MANAGERS, LLC | $9 748 000 | 100 000 | 0,21% | Akcje |
| Iron Triangle Partners LP | $9 508 383 | 230 730 | 0,20% | Akcje |
| Atika Capital Management LLC | $9 417 738 | 96 612 | 0,20% | Akcje |
| FIRST TRUST ADVISORS LP | $9 177 936 | 94 152 | 0,20% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $9 133 876 | 93 700 | 0,20% | Opcja kupna |
| BlackRock, Inc. | $9 082 017 | 93 168 | 0,19% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $8 952 368 | 91 838 | 0,19% | Akcje |
| VICTORY CAPITAL MANAGEMENT INC | $8 608 947 | 88 315 | 0,18% | Akcje |
| Russell Investments Group, Ltd. | $8 608 137 | 88 306 | 0,18% | Akcje |
| AMERICAN CENTURY COMPANIES INC | $8 564 593 | 87 860 | 0,18% | Akcje |
| Rhenman & Partners Asset Management AB | $8 395 660 | 86 127 | 0,18% | Akcje |
| Caption Management, LLC | $7 505 960 | 77 000 | 0,16% | Opcja sprzedaży |
| SAMLYN CAPITAL, LLC | $7 304 859 | 74 937 | 0,16% | Akcje |
| Moody Aldrich Partners LLC | $7 267 329 | 74 552 | 0,16% | Akcje |
| Swiss National Bank | $7 194 024 | 73 800 | 0,15% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7 116 040 | 73 000 | 0,15% | Opcja sprzedaży |
| MERCER GLOBAL ADVISORS INC /ADV | $6 402 779 | 65 683 | 0,14% | Akcje |
| LPL Financial LLC | $6 365 029 | 65 295 | 0,14% | Akcje |
| SummitTX Capital, L.P. | $6 225 658 | 63 866 | 0,13% | Akcje |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $6 124 571 | 62 829 | 0,13% | Akcje |
| NEW YORK STATE COMMON RETIREMENT FUND | $5 853 479 | 60 048 | 0,13% | Akcje |
| Sio Capital Management, LLC | $5 776 080 | 59 254 | 0,12% | Akcje |
| RHUMBLINE ADVISERS | $5 704 614 | 58 521 | 0,12% | Akcje |
| Jones Hill Capital LP | $5 566 108 | 57 100 | 0,12% | Akcje |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC | $5 560 454 | 57 042 | 0,12% | Akcje |
| ALPS ADVISORS INC | $5 388 792 | 55 281 | 0,12% | Akcje |
| CITIGROUP INC | $5 274 935 | 54 113 | 0,11% | Akcje |
| HighVista Strategies LLC | $4 983 665 | 51 125 | 0,11% | Akcje |
| Burkehill Global Management, LP | $4 874 000 | 50 000 | 0,10% | Akcje |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $4 738 406 | 48 609 | 0,10% | Akcje |
| JANE STREET GROUP, LLC | $4 484 080 | 46 000 | 0,10% | Opcja kupna |
| Seven Fleet Capital Management LP | $4 257 147 | 43 672 | 0,09% | Akcje |
| CITADEL ADVISORS LLC | $4 230 632 | 43 400 | 0,09% | Opcja sprzedaży |
| Schonfeld Strategic Advisors LLC | $4 223 027 | 43 322 | 0,09% | Akcje |
| D. E. Shaw & Co., Inc. | $4 184 621 | 42 928 | 0,09% | Akcje |
| JANE STREET GROUP, LLC | $3 986 932 | 40 900 | 0,09% | Opcja sprzedaży |
Insiderzy spółki 36 insiderów · 10 dyrektorzy generalni · 14 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Ryan Savitz | EVP, CFO & CBO | 9 lipca 2026 M | 0 | 0 | 4 | $-3 857 151 |
| Simrat Randhawa | EVP, Head of R&D | 1 czerwca 2026 M | 4 000 | 0 | 3 | $-2 404 077 |
| David Wayne Nichols | Chief Technical Officer | 1 sierpnia 2022 A | 14 306 | 0 | 0 | $0 |
| Lisa Olson | Title: Head of Research and Chief Scientific Officer Exhibit 24.1: Power of Attorney | 1 sierpnia 2022 A | 14 264 | 0 | 0 | $0 |
| Jeffrey Humphrey | Chief Medical Officer | 1 sierpnia 2022 A | — | 0 | 0 | $0 |
| John C. Davis JR | Title: Head of Research and Development and Chief Medical Officer | 11 lutego 2021 A | 8 304 | 0 | 0 | $0 |
| Zoran Zdraveski | Title: Secretary and Chief Legal and Technology Operations Officer | 11 lutego 2021 A | 140 092 | 0 | 0 | $0 |
| Christina K. Isacson | Chief Business Officer | 10 lutego 2020 A | 103 531 | 0 | 0 | $0 |
| Jason Ryan | Title: Chief Operating and Financial Officer | 10 lutego 2020 A | — | 0 | 0 | $0 |
| COOKE MICHAEL P. | Chief Scientific Officer | 5 lutego 2019 A | 293 023 | 0 | 0 | $0 |
| Jonathan Violin | Dyrektor | 22 maja 2025 A | — | 0 | 0 | $0 |
| Paula Soteropoulos | Dyrektor | 22 maja 2025 A | — | 0 | 0 | $0 |
| Steven J. Romano | Dyrektor | 22 maja 2025 A | — | 0 | 0 | $0 |
| Alison Frances Lawton | Dyrektor | 22 maja 2025 A | — | 0 | 0 | $0 |
| MOULDER LEON O JR | Dyrektor | 23 maja 2024 A | 1 436 745 | 0 | 0 | $0 |
| Michael Vasconcelles | Dyrektor | 15 sierpnia 2022 A | — | 0 | 0 | $0 |
| David Scadden | Dyrektor | 28 czerwca 2022 A | 228 175 | 0 | 0 | $0 |
| Jeffrey W. Albers | Dyrektor | 28 czerwca 2022 A | 4 152 | 0 | 0 | $0 |
| Thomas O Daniel | Dyrektor | 28 czerwca 2022 A | 101 926 | 0 | 0 | $0 |
| Bruce Booth | Dyrektor | 28 czerwca 2022 A | 1 250 000 | 0 | 0 | $0 |
| Amy L Ronneberg | Dyrektor | 28 czerwca 2022 A | 593 611 | 0 | 0 | $0 |
| Alexis Borisy | Dyrektor | 26 sierpnia 2021 J | 4 100 | 0 | 0 | $0 |
| Michael W Bonney | Dyrektor | 1 czerwca 2021 A | 215 346 | 0 | 0 | $0 |
| Blake Byers | Dyrektor | 5 czerwca 2020 A | 3 339 137 | 0 | 0 | $0 |
| Atlas Venture Fund X, L.P. | Posiadacz 10% | 11 lutego 2021 J | 3 148 399 | 0 | 0 | $0 |
| Adam M Veness | — | 13 sierpnia 2026 M | 15 000 | 0 | 5 | $-4 632 790 |
| Anne Mcgeorge | — | 10 sierpnia 2026 M | 0 | 0 | 5 | $-844 822 |
| Simon Read | — | 10 sierpnia 2026 M | 0 | 0 | 6 | $-304 232 |
| Marino Garcia | — | 7 sierpnia 2026 M | 65 292 | 0 | 7 | $-17 945 450 |
| Sujay Kango | — | 21 maja 2026 A | — | 0 | 0 | $0 |
| Edward Carr | — | 12 marca 2026 M | 0 | 0 | 5 | $-3 559 495 |
| Caren Deardorf | — | 30 listopada 2022 A | 19 762 | 0 | 0 | $0 |
| Kristen Stants | — | 30 listopada 2022 A | 20 264 | 0 | 0 | $0 |
| Stephen F. Mahoney | — | 30 listopada 2022 A | 17 264 | 0 | 0 | $0 |
| Thomas W. Beetham | — | 30 listopada 2022 A | 19 897 | 0 | 0 | $0 |
| Jason Gardner | — | 30 listopada 2022 A | 292 872 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 4 akcje
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Fairmount Funds Management LLC, Fairmount Healthcare Fund II L.P., Peter Evan Harwin, Tomas Kiselak ×5 zgłoszenia | 25 listopada 2025 | 4,90% | Aneks | — | SEC |
| Avidity Partners Management LP, Avidity Partners Management (GP) LLC, Avidity Capital Partners Fund (GP) LP, Avidity Capital Partners (GP) LLC, Avidity Private Master Fund I LP, Michael Gregory ×4 zgłoszenia | 19 listopada 2025 | 4,90% | Aneks | Inwestycja pasywna | SEC |
| Viridian, LLC ×2 zgłoszenia | 12 września 2024 | — | Pierwotne zgłoszenie | — | SEC |
| ATLAS VENTURE FUND X, L.P., ATLAS VENTURE ASSOCIATES X, L.P., Atlas Venture Associates X, LLC, Atlas Venture Opportunity Fund I, L.P., Atlas Venture Associates Opportunity I, L.P., Atlas Venture Associates Opportunity I, LLC ×4 zgłoszenia | 15 września 2023 | — | Pierwotne zgłoszenie | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 49 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| IBRN · iShares Trust | 5,20% | 3 652 SH | 8 sierpnia 2026 | Dziennie |
| LFSC · RBB Fund, Inc. | 3,09% | 34 884 NS | 31 maja 2026 | N-PORT |
| SBIO · ALPS ETF Trust | 2,64% | 45 839 NS | 31 maja 2026 | N-PORT |
| BBC · ETFis Series Trust I | 1,54% | 6 551 NS | 30 kwietnia 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,57% | 33 605 NS | 30 kwietnia 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,47% | 55 660 NS | 30 kwietnia 2026 | N-PORT |
| IWO · iShares Trust | 0,32% | 430 720 SH | 8 sierpnia 2026 | Dziennie |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,27% | 50 626 SH | 8 sierpnia 2026 | Dziennie |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,26% | 76 617 NS | 31 maja 2026 | N-PORT |
| MMSC · First Trust Exchange-Traded Fund VI… | 0,20% | 1 151 NS | 31 maja 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,18% | 24 819 NS | 30 kwietnia 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,17% | 14 250 NS | 30 kwietnia 2026 | N-PORT |
| IWM · iShares Trust | 0,16% | 1 198 637 SH | 8 sierpnia 2026 | Dziennie |
| VFMO · VANGUARD WELLINGTON FUND | 0,15% | 29 943 SH | 8 sierpnia 2026 | Dziennie |
| FFSM · FIDELITY COVINGTON TRUST | 0,15% | 22 043 NS | 30 kwietnia 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,14% | 272 370 SH | 8 sierpnia 2026 | Dziennie |
| ISCV · iShares Trust | 0,13% | 8 330 SH | 8 sierpnia 2026 | Dziennie |
| RSSL · Global X Funds | 0,10% | 15 526 NS | 30 kwietnia 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,09% | 5 190 NS | 30 kwietnia 2026 | N-PORT |
| SMMV · iShares Trust | 0,09% | 2 477 SH | 8 sierpnia 2026 | Dziennie |
| ITWO · ProShares Trust | 0,08% | 1 687 NS | 31 maja 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,07% | 177 996 NS | 31 maja 2026 | N-PORT |
| ISCB · iShares Trust | 0,07% | 1 709 SH | 8 sierpnia 2026 | Dziennie |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,06% | 66 NS | 31 maja 2026 | N-PORT |
| ESML · iShares Trust | 0,06% | 15 524 SH | 8 sierpnia 2026 | Dziennie |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,06% | 15 079 SH | 8 sierpnia 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,05% | 110 607 SH | 8 sierpnia 2026 | Dziennie |
| GSSC · Goldman Sachs ETF Trust | 0,05% | 5 283 NS | 31 maja 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,05% | 16 047 NS | 30 kwietnia 2026 | N-PORT |
| UWM · ProShares Trust | 0,05% | 1 320 NS | 31 maja 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,04% | 71 218 NS | 30 kwietnia 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,04% | 457 520 SH | 8 sierpnia 2026 | Dziennie |
| URTY · ProShares Trust | 0,04% | 1 340 NS | 31 maja 2026 | N-PORT |
| WSML · iShares Trust | 0,03% | 2 127 SH | 8 sierpnia 2026 | Dziennie |
| HDG · ProShares Trust | 0,01% | 34 NS | 31 maja 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 3 958 NS | 30 kwietnia 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 869 NS | 31 maja 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 1 650 280 SH | 8 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 3 889 SH | 8 sierpnia 2026 | Dziennie |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 11 461 NS | 31 maja 2026 | N-PORT |
| IWV · iShares Trust | 0,01% | 12 550 SH | 8 sierpnia 2026 | Dziennie |
| ITOT · iShares Trust | 0,01% | 54 504 SH | 8 sierpnia 2026 | Dziennie |
| DFAU · Dimensional ETF Trust | 0,01% | 7 297 NS | 30 kwietnia 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,01% | 27 975 NS | 30 kwietnia 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 21 529 NS | 31 maja 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 770 NS | 30 kwietnia 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 4 404 NS | 30 kwietnia 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 1 591 NS | 31 maja 2026 | N-PORT |
| AVSU · AMERICAN CENTURY ETF TRUST | 0,00% | 31 NS | 31 maja 2026 | N-PORT |